Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL

NCT01914744 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin Lymphoma
Hepatitis B Reactivation

Interventions

DRUG: Entecavir
DRUG: Lamivudine

Sponsor

Fudan University